Chlamydia

GLXA-directed Antibody Protects Mice From Human C. Trachomatis

Published in TB and Outbreaks Week, September 11th, 2001

by N.R. Saltmarsh, staff medical writer - An anti-idiotypic monoclonal antibody vaccine against chlamydia protects mice from infectious challenge with a human urogenital strain of Chlamydia trachomatis, according to a new report in Vaccine.

The finding suggests a possible new avenue for chlamydia vaccine research, which has yielded little new information in the past three decades, said J.A. Whittum-Hudson and colleagues in the United States.

"No vaccine candidate has protected against heterologous challenge, nor at more than one site of infection," they pointed out. "The majority of experimental anti-chlamydial vaccines to date have...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of TB and Outbreaks Week

Source: TB and Outbreaks Week (2001-09-11)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry